Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.76 USD | +1.44% | -2.09% | -10.70% |
04:18pm | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
03:30pm | Pfizer: presents new data at ASCO 2024 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.70% | 144B | |
+26.58% | 661B | |
+27.40% | 566B | |
-6.32% | 352B | |
+20.30% | 332B | |
+3.21% | 283B | |
+14.13% | 231B | |
+5.17% | 200B | |
-9.04% | 195B | |
-4.90% | 145B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Guggenheim Initiates Pfizer With Buy Rating, Price Target is $36